Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
For highly sensitive individuals, even one-tenth of the therapeutic concentration may produce noticeable appetite modulation
Light exposure considerations Ultraviolet and visible light accelerate peptide degradation through photochemical reactions
The CagriSema trials used 2.4 mg as the target, and the Phase 3 monotherapy data also used 2.4 mg
HOW What you need: Peptide vial (powder form) Bacteriostatic water (0.9% benzyl alcohol) 3ml syringe for drawing water Alcohol swabs Refrigerator for storage Reconstitution process: Step 1: Remove plastic cap from peptide vial
Background and Mechanisms of Action BPC-157 BPC-157 was first characterized and isolated from gastric mucosal extracts and enzymatic preparations in the 1990s through systematic protein fractionation studies
Because research-market material is sold outside any approved supply chain, its identity and purity are unverified: published trial data describe a characterized study drug, not the contents of an arbitrary vial, so identity confirmation (for example by mass spectrometry and HPLC) and a batch certificate of analysis are the minimum a rigorous research setting should require
